Cargando…
Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
OBJECTIVE: While pulmonary arterial hypertension (PAH) is rare in infants and children, it results in substantial morbidity and mortality. In recent years, prognosis has improved, coinciding with the introduction of new PAH‐targeted therapies, although much of their use in children is off‐label. Evi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771736/ https://www.ncbi.nlm.nih.gov/pubmed/31313530 http://dx.doi.org/10.1002/ppul.24442 |